David Gray
Impact in
-
- Virus-based gene therapy research
- Mesenchymal stem cell research
Papers in
-
- CRISPR and Genetic Engineering 5
- Genetics 3
- Hemoglobinopathies and Related Disorders 2
- Virus-based gene therapy research 2
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Donald B. Kohn (3 shared papers)Anastasia Lomova (1 shared paper)Richard A. Morgan (1 shared paper)Caroline Y. Kuo (2 shared papers)Joseph Long (2 shared papers)Andreas Reik (2 shared papers)Michael C. Holmes (2 shared papers)Gregory J. Cost (1 shared paper)
- Journals
- Blood (2 papers)Cell stem cell (1 paper)The CRISPR Journal (1 paper)Molecular Therapy — Nucleic Acids (1 paper)Australian and New Zealand Journal of Surgery (1 paper)
- Partner nations
- United States
In The Last Decade
David Gray
7 papers receiving 196 citations
Peers
Comparison fields: 5 of 42
- Genetics 36
- Business and International Management 6
- Genetics 85
- Hematology 33
- Molecular Biology 131
Countries citing papers authored by David Gray
This map shows the geographic impact of David Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gray more than expected).
Fields of papers citing papers by David Gray
This network shows the impact of papers produced by David Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gray. The network helps show where David Gray may publish in the future.
Co-authors
The 19 scholars most cited alongside David Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 164 | |
| 2 | 2021 | 19 | |
| 3 | 2021 | 7 | |
| 4 | 2018 | 4 | |
| 5 | 2013 | 2 | |
| 6 | 1982 | 1 | |
| 7 | Gene Editing of Bruton's Tyrosine Kinase for Treatment of X-Linked Agammaglobulinemia | 2020 | 1 |
About David Gray
David Gray is a scholar working on Molecular Biology, Genetics, Oncology, Genetics and Immunology, having authored 7 papers that have together received 198 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), CAR-T cell therapy research (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Virus-based gene therapy research (2 papers), Prenatal Screening and Diagnostics (1 paper), Dental Education, Practice, Research (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Genetics (36 citations), Business and International Management (6 citations), Genetics (85 citations), Hematology (33 citations) and Molecular Biology (131 citations). David Gray has collaborated with scholars based in United States. Frequent co-authors include Donald B. Kohn, Anastasia Lomova, Richard A. Morgan, Caroline Y. Kuo, Joseph Long, Andreas Reik, Michael C. Holmes, Gregory J. Cost, Pauline Rimmelé and Alok V. Joglekar. Their work appears in journals such as Blood, Cell stem cell, The CRISPR Journal, Molecular Therapy — Nucleic Acids and Australian and New Zealand Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.